Global Fluralaner API Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Fluralaner API Market Research Report 2024
Fluralaner, isoxazoline class compound, is a systemic insecticide and acaricide with antiparasitic activity against cat and dog fleas and ticks. Fluralaner is an inhibitor of the arthropod nervous system. Fluralaner inhibits γ-aminobutyric acid (GABA)-gated chloride channels (GABACls) and L-glutamate-gated chloride channels (GluCls). Potency of fluralaner is comparable to fipronil (a phenylpyrazole ectoparasiticide). Fluralaner API in this report.
According to Mr Accuracy reports’s new survey, global Fluralaner API market is projected to reach US$ 101 million in 2034, increasing from US$ 67 million in 2024, with the CAGR of 4.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fluralaner API market research.
Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fluralaner API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology
Segment by Type
Purity above 98%
Purity below 98%
Oral Drug
Topical Drug
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Fluralaner API report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Fluralaner API market is projected to reach US$ 101 million in 2034, increasing from US$ 67 million in 2024, with the CAGR of 4.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Fluralaner API market research.
Global key manufacturers of Fluralaner API include Nissan Chemical, Hikal, Hubei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu, etc. Global top five manufacturers hold a share about 85%. Asia-Pacific is the largest market of Fluralaner API, holds a share over 35%. In terms of product, purity above 98% ones hold a larger segment, with a share over 75%. And in terms of application, the largest application is oral drug, with a share of over 70%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fluralaner API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Nissan Chemical
Hikal
Hubei Masteam Bio-tech
Jiangsu Rivocean
Shaanxi Dideu
Zhejiang Gihi Chemicals
Hunan Huateng Pharmaceutical
Taizhou Crene Biotechnology
Segment by Type
Purity above 98%
Purity below 98%
Segment by Application
Oral Drug
Topical Drug
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Fluralaner API report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices